Evidence map›Paper›PMID 26916347›Full record

ArticleJournal of the American Chemical Society2016

Supramolecular Probes for Assessing Glutamine Uptake Enable Semi-Quantitative Metabolic Models in Single Cells.

Min Xue, Wei Wei, Yapeng Su, Dazy Johnson, James R Heath

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 38 citations in OpenAlex.

  1. Non-Mass Spectrometric Targeted Single-Cell Metabolomics.Trends in analytical chemistry : TRAC · 2023
    Article
  2. Review
  3. The Intriguing Landscape of Single-Cell Protein Analysis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Review
  4. Article
  5. Glutamine Imaging: A New Avenue for Glioma Management.AJNR. American journal of neuroradiology · 2022
    Review
  6. Review
  7. Article
  8. A guide to interrogating immunometabolism.Nature reviews. Immunology · 2021
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Min XueDivision of Chemistry and Chemical Engineering, California Institute of Technology , Pasadena, California 91125, United States.
Wei WeiDepartment of Molecular and Medical Pharmacology, University of California , Los Angeles, California 90095, United States.
Yapeng SuDivision of Chemistry and Chemical Engineering, California Institute of Technology , Pasadena, California 91125, United States.
Dazy JohnsonDepartment of Molecular and Medical Pharmacology, University of California , Los Angeles, California 90095, United States.
James R HeathDivision of Chemistry and Chemical Engineering, California Institute of Technology , Pasadena, California 91125, United States.
University of California, Los Angeles · USCalifornia Institute of Technology · US

Funding

Repurposing of cancer therapeutics for treatment of patients with COVID-19 diseaseU54CA199090 · NCI · INSTITUTE FOR SYSTEMS BIOLOGY · PI HEATH, JAMES R., RIBAS, ANTONI · 2015 to 2020
$11.4M
Strategies for Distinguishing Success in Immunotherapy Treatments (PQ20)R01CA170689 · NCI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI HEATH, JAMES R., RIBAS, ANTONI · 2012 to 2015
$2.5M
NCI NIH HHS 1U54 CA199090-01NCI NIH HHS R01 CA170689NCI NIH HHS R01-CA170689NCI NIH HHS U54 CA199090
6 · The paper itself

Abstract

We describe a supramolecular surface competition assay for quantifying glutamine uptake from single cells. Cy3-labeled cyclodextrins were immobilized on a glass surface as a supramolecular host/FRET donor, and adamantane-BHQ2 conjugates were employed as the guest/quencher. An adamantane-labeled glutamine analog was selected through screening a library of compounds and validated by cell uptake experiments. When integrated onto a single cell barcode chip with a multiplex panel of 15 other metabolites, associated metabolic enzymes, and phosphoproteins, the resultant data provided input for a steady-state model that describes energy potential in single cells and correlates that potential with receptor tyrosine kinase signaling. We utilize this integrated assay to interrogate a dose-dependent response of model brain cancer cells to EGFR inhibition. We find that low-dose (1 μM erlotinib) drugging actually increases cellular energy potential even as glucose uptake and phosphoprotein signaling is repressed. We also identify new interactions between phosphoprotein signaling and cellular energy processes that may help explain the facile resistance exhibited by certain cancer patients to EGFR inhibitors.

Indexed as

Brain NeoplasmsCarbocyaninesCell Line, TumorDose-Response Relationship, DrugErbB ReceptorsErlotinib HydrochlorideFluorescence Resonance Energy TransferGlioblastomaGlutamineHumansMolecular ProbesCarbocyaninescyanine dye 3EGFR protein, humanErbB ReceptorsErlotinib HydrochlorideGlutamineMolecular Probes

Identifiers

PMID26916347
PMCPMC4887079
OpenAlexW2286473546

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.